Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients With Psoriatic Arthritis
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
